These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 20332770)

  • 1. Dyspeptic symptom development after discontinuation of a proton pump inhibitor: a double-blind placebo-controlled trial.
    Niklasson A; Lindström L; Simrén M; Lindberg G; Björnsson E
    Am J Gastroenterol; 2010 Jul; 105(7):1531-7. PubMed ID: 20332770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton-pump inhibitor therapy induces acid-related symptoms in healthy volunteers after withdrawal of therapy.
    Reimer C; Søndergaard B; Hilsted L; Bytzer P
    Gastroenterology; 2009 Jul; 137(1):80-7, 87.e1. PubMed ID: 19362552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of pantoprazole and Helicobacter pylori therapy on uninvestigated dyspeptic patients.
    Baysal B; Şentürk H; Masri O; Tozlu M; Kayar Y; Arabacı E; Uysal Ö; Buğdacı MS; İnce AT
    Turk J Gastroenterol; 2015 Jan; 26(1):6-14. PubMed ID: 25698264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum gastrin and chromogranin A during medium- and long-term acid suppressive therapy: a case-control study.
    Sanduleanu S; Stridsberg M; Jonkers D; Hameeteman W; Biemond I; Lundqvist G; Lamers C; Stockbrügger RW
    Aliment Pharmacol Ther; 1999 Feb; 13(2):145-53. PubMed ID: 10102943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized controlled trial of effectiveness of lafutidine versus pantoprazole in uninvestigated dyspepsia.
    Maity S; Choudhury S; Hazra A; Das AK
    Indian J Pharmacol; 2014; 46(5):498-502. PubMed ID: 25298578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spirulina Platensis Attenuates Rebound Dyspeptic Symptoms After Proton Pump Inhibitors' Discontinuation: Phase 2 Placebo-controlled Trial.
    Gronevalt ATM; Bertolin TE; Forcelini CM; Polletto PHM; Pasetti BW; Graeff DB; Rodriguez R; Fornari F
    Altern Ther Health Med; 2024 Feb; 30(2):18-24. PubMed ID: 38401078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of pantoprazole 20 mg once daily treatment in patients with ulcer-like functional dyspepsia.
    van Rensburg C; Berghöfer P; Enns R; Dattani ID; Maritz JF; Gonzalez Carro P; Fischer R; Schwan T
    Curr Med Res Opin; 2008 Jul; 24(7):2009-18. PubMed ID: 18534050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Withholding Pantoprazole for Stress Ulcer Prophylaxis in Critically Ill Patients: A Pilot Randomized Clinical Trial and Meta-Analysis.
    Alhazzani W; Guyatt G; Alshahrani M; Deane AM; Marshall JC; Hall R; Muscedere J; English SW; Lauzier F; Thabane L; Arabi YM; Karachi T; Rochwerg B; Finfer S; Daneman N; Alshamsi F; Zytaruk N; Heel-Ansdell D; Cook D;
    Crit Care Med; 2017 Jul; 45(7):1121-1129. PubMed ID: 28459708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomised clinical trial: daily pantoprazole magnesium 40 mg vs. esomeprazole 40 mg for gastro-oesophageal reflux disease, assessed by endoscopy and symptoms.
    Moraes-Filho JP; Pedroso M; Quigley EM;
    Aliment Pharmacol Ther; 2014 Jan; 39(1):47-56. PubMed ID: 24299323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomised clinical trial: rabeprazole improves symptoms in patients with functional dyspepsia in Japan.
    Iwakiri R; Tominaga K; Furuta K; Inamori M; Furuta T; Masuyama H; Kanke K; Nagahara A; Haruma K; Kinoshita Y; Higuchi K; Takahashi S; Kusano M; Iwakiri K; Kato M; Hongo M; Hiraishi H; Watanabe S; Miwa H; Naito Y; Fujimoto K; Arakawa T
    Aliment Pharmacol Ther; 2013 Oct; 38(7):729-40. PubMed ID: 23957383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of sequential and standard triple-drug regimen for Helicobacter pylori eradication: a 14-day, open-label, randomized, prospective, parallel-arm study in adult patients with nonulcer dyspepsia.
    Uygun A; Kadayifci A; Yesilova Z; Safali M; Ilgan S; Karaeren N
    Clin Ther; 2008 Mar; 30(3):528-34. PubMed ID: 18405790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and pathophysiological consequences of on-demand treatment with PPI in endoscopy-negative reflux disease. Is rebound hypersecretion of acid a problem?
    Juul-Hansen P; Rydning A
    Scand J Gastroenterol; 2011 Apr; 46(4):398-405. PubMed ID: 21142586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological dependency in chronic treatment of gastroesophageal reflux disease: a randomized controlled clinical trial.
    van der Velden AW; de Wit NJ; Quartero AO; Grobbee DE; Numans ME
    Digestion; 2010; 81(1):43-52. PubMed ID: 20029208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intragastric pH and serum gastrin during administration of different doses of pantoprazole in healthy subjects.
    Koop H; Kuly S; Flüg M; Eissele R; Mönnikes H; Rose K; Lühmann R; Schneider A; Fischer R; Arnold R
    Eur J Gastroenterol Hepatol; 1996 Sep; 8(9):915-8. PubMed ID: 8889461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early relief of upper gastrointestinal dyspeptic symptoms: a survey of empirical therapy with pantoprazole in Canadian clinical practice.
    Armstrong D; Kazim F; Gervais M; Pyzyk M
    Can J Gastroenterol; 2002 Jul; 16(7):439-50. PubMed ID: 12177723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of non-steroidal anti-inflammatory drug-induced gastrointestinal symptoms during proton pump inhibitor treatment: are G-protein β3 subunit genotype, Helicobacter pylori status, and environmental factors response modifiers?
    Holtmann G; van Rensburg C; Schwan T; Sander P; Siffert W
    Digestion; 2011; 84(4):289-98. PubMed ID: 22041889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomised trial of the effect of a gastrin/CCK
    Boyce M; van den Berg F; Mitchell T; Darwin K; Warrington S
    Eur J Clin Pharmacol; 2017 Feb; 73(2):129-139. PubMed ID: 27796466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of pantoprazole on the course of reflux-associated laryngitis: a placebo-controlled double-blind crossover study.
    Eherer AJ; Habermann W; Hammer HF; Kiesler K; Friedrich G; Krejs GJ
    Scand J Gastroenterol; 2003 May; 38(5):462-7. PubMed ID: 12795454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of pantoprazole on 24-h intragastric pH and serum gastrin in humans.
    Londong W
    Aliment Pharmacol Ther; 1994; 8 Suppl 1():39-46. PubMed ID: 8180293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Editorial: just how "difficult" is it to withdraw PPI treatment?
    Howden CW; Kahrilas PJ
    Am J Gastroenterol; 2010 Jul; 105(7):1538-40. PubMed ID: 20606660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.